John J. Alam - 08 Jun 2026 Form 4 Insider Report for CervoMed Inc. (CRVO)

Reporting relationship: CEO & President, Director, 10%+ Owner
Issuer ticker: CRVO
Reported as of: 08 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 19:42:12 UTC
Prior SEC filing: 13 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person

Key filing fact

John J. Alam filed Form 4 for CervoMed Inc. (CRVO) on 10 Jun 2026.

Key facts

This page summarizes John J. Alam's Form 4 filing for CervoMed Inc. (CRVO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2026, 19:42.

Change

Previous filing in this sequence was filed on 13 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001197014 Primary reporting owner

ALAM JOHN J

Relationship: CEO & President, Director, 10%+ Owner
Address: 20 PARK PLAZA, SUITE 424, BOSTON
Signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person
Signature date: 10 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +8,150
Change %
Price: $0.000000^*
Shares after: 8,150
Date: 08 Jun 2026
Ownership: By Spouse
Underlying class: Common Stock
Underlying amount: 8,150
Exercise price: $2.91
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, PharmD., the Reporting Person's spouse and a non-employee director of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Footnote F2

The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Dr. Gregoire's continued service through the applicable vesting date.